{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:32:50Z","timestamp":1793068370148,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"vor","delay-in-days":101,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cultivation Projects of Capital Center for Children's Health, Capital Medical University","award":["LCYJ-2023-13"],"award-info":[{"award-number":["LCYJ-2023-13"]}],"id":[{"id":"https:\/\/ror.org\/013xs5b60","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Finance Bureau","award":["No. 11000024T000002831273"],"award-info":[{"award-number":["No. 11000024T000002831273"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-026-02312-8","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T18:14:11Z","timestamp":1784398451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical spectrum and ascertainment pathways in pediatric female dystrophinopathy"],"prefix":"10.1186","volume":"52","author":[{"given":"Hui","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"1","key":"2312_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7(1):13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2312_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ncl.2013.04.004","volume":"31","author":"PB Shieh","year":"2013","unstructured":"Shieh PB. Muscular dystrophies and other genetic myopathies. Neurol Clin. 2013;31(4):1009\u201329. https:\/\/doi.org\/10.1016\/j.ncl.2013.04.004.","journal-title":"Neurol Clin"},{"issue":"3","key":"2312_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251\u201367. https:\/\/doi.org\/10.1016\/S1474-4422(18)30024-3.","journal-title":"Lancet Neurol"},{"key":"2312_CR4","doi-asserted-by":"publisher","unstructured":"Sarkozy A, Quinlivan R, Bourke JP et al. 263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Neuromuscul Disord. 2023;33(3):274\u2013284. https:\/\/doi.org\/10.1016\/j.nmd.2023.01.003","DOI":"10.1016\/j.nmd.2023.01.003"},{"issue":"8","key":"2312_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nmd.2010.05.010","volume":"20","author":"P Soltanzadeh","year":"2010","unstructured":"Soltanzadeh P, Friez MJ, Dunn D, et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord. 2010;20(8):499\u2013504. https:\/\/doi.org\/10.1016\/j.nmd.2010.05.010.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"2312_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1017\/cjn.2016.448","volume":"44","author":"A Cotta","year":"2017","unstructured":"Cotta A, Paim JF, Carvalho E, et al. Phenotypic Variability of Dystrophinopathy Symptomatic Female Carriers. Can J Neurol Sci. 2017;44(3):304\u201310. https:\/\/doi.org\/10.1017\/cjn.2016.448.","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"2312_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3988\/jcn.2015.11.3.248","volume":"11","author":"SH Lee","year":"2015","unstructured":"Lee SH, Lee JH, Lee KA, Choi YC. Clinical and Genetic Characterization of Female Dystrophinopathy. J Clin Neurol. 2015;11(3):248\u201351. https:\/\/doi.org\/10.3988\/jcn.2015.11.3.248.","journal-title":"J Clin Neurol"},{"issue":"9170","key":"2312_CR8","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/S0140-6736(98)10028-4","volume":"353","author":"EM Hoogerwaard","year":"1999","unstructured":"Hoogerwaard EM, Bakker E, Ippel PF, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet. 1999;353(9170):2116\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(98)10028-4.","journal-title":"Lancet"},{"key":"2312_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2018.03.015","volume":"388","author":"J Finsterer","year":"2018","unstructured":"Finsterer J, Stollberger C. Muscle, cardiac, and cerebral manifestations in female carriers of dystrophin variants. J Neurol Sci. 2018;388:107\u20138. https:\/\/doi.org\/10.1016\/j.jns.2018.03.015.","journal-title":"J Neurol Sci"},{"issue":"8","key":"2312_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ejhg.2012.269","volume":"21","author":"S Mercier","year":"2013","unstructured":"Mercier S, Toutain A, Toussaint A, et al. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age. Eur J Hum Genet. 2013;21(8):855\u201363. https:\/\/doi.org\/10.1038\/ejhg.2012.269.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"2312_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00439-016-1666-6","volume":"135","author":"E Viggiano","year":"2016","unstructured":"Viggiano E, Ergoli M, Picillo E, Politano L. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Hum Genet. 2016;135(7):685\u201398. https:\/\/doi.org\/10.1007\/s00439-016-1666-6.","journal-title":"Hum Genet"},{"key":"2312_CR12","doi-asserted-by":"publisher","unstructured":"Viggiano E, Picillo E, Ergoli M, Cirillo A, Del Gaudio S, Politano L. Skewed X-chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy. J Gene Med. 2017;19(4). https:\/\/doi.org\/10.1002\/jgm.2952.","DOI":"10.1002\/jgm.2952"},{"issue":"8","key":"2312_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/dmcn.15496","volume":"65","author":"SLS Houwen-van Opstal","year":"2023","unstructured":"Houwen-van Opstal SLS, Tak RO, Pelsma M, et al. Long-term outcomes for females with early-onset dystrophinopathy. Dev Med Child Neurol. 2023;65(8):1093\u2013104. https:\/\/doi.org\/10.1111\/dmcn.15496.","journal-title":"Dev Med Child Neurol"},{"issue":"10","key":"2312_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.nmd.2023.08.008","volume":"33","author":"C Liu","year":"2023","unstructured":"Liu C, Ma J, Lu Y, et al. Clinical, pathological, and genetic characterization in a large Chinese cohort with female dystrophinopathy. Neuromuscul Disord. 2023;33(10):728\u201336. https:\/\/doi.org\/10.1016\/j.nmd.2023.08.008.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"2312_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00415-025-12987-4","volume":"272","author":"F Riguzzi","year":"2025","unstructured":"Riguzzi F, Sabbatini D, Fusto A, et al. Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations. J Neurol. 2025;272(3):244. https:\/\/doi.org\/10.1007\/s00415-025-12987-4.","journal-title":"J Neurol"},{"issue":"3","key":"2312_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/jpn.JPN_89_20","volume":"16","author":"R Suthar","year":"2021","unstructured":"Suthar R, Kesavan S, Sharawat IK, et al. The expanding spectrum of dystrophinopathies: hyperCKemia to manifest female carriers. J Pediatr Neurosci. 2021;16(3):206\u201311. https:\/\/doi.org\/10.4103\/jpn.JPN_89_20.","journal-title":"J Pediatr Neurosci"},{"issue":"1\u20132","key":"2312_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/08830738221147808","volume":"38","author":"D Pasca","year":"2023","unstructured":"Pasca D, Ginsberg M. Causes of HyperCKemia in Children: A Retrospective Cohort Study. J Child Neurol. 2023;38(1\u20132):25\u201330. https:\/\/doi.org\/10.1177\/08830738221147808.","journal-title":"J Child Neurol"},{"issue":"9","key":"2312_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.nmd.2022.07.401","volume":"32","author":"WK Wong","year":"2022","unstructured":"Wong WK, Bryen SJ, Bournazos A, et al. A genetic basis is identified in 74% cases of paediatric hyperCKaemia without weakness presenting to a tertiary paediatric neuromuscular centre. Neuromuscul Disord. 2022;32(9):707\u201317. https:\/\/doi.org\/10.1016\/j.nmd.2022.07.401.","journal-title":"Neuromuscul Disord"},{"issue":"17","key":"2312_CR19","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","volume":"275","author":"L Politano","year":"1996","unstructured":"Politano L, Nigro V, Nigro G, et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA. 1996;275(17):1335\u20138. https:\/\/doi.org\/10.1001\/jama.1996.03530410049032.","journal-title":"JAMA"},{"issue":"2","key":"2312_CR20","doi-asserted-by":"publisher","first-page":"e001977","DOI":"10.1136\/openhrt-2022-001977","volume":"9","author":"J Bourke","year":"2022","unstructured":"Bourke J, Turner C, Bradlow W, et al. Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations. Open Heart. 2022;9(2):e001977. https:\/\/doi.org\/10.1136\/openhrt-2022-001977.","journal-title":"Open Heart"},{"issue":"10","key":"2312_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2217\/bmm-2020-0801","volume":"15","author":"SP Sherlock","year":"2021","unstructured":"Sherlock SP, Zhang Y, Binks M, Marraffino S. Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests. Biomark Med. 2021;15(10):761\u201373. https:\/\/doi.org\/10.2217\/bmm-2020-0801.","journal-title":"Biomark Med"},{"issue":"9","key":"2312_CR22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1468-1331.2012.03753.x","volume":"19","author":"G Tasca","year":"2012","unstructured":"Tasca G, Monforte M, Iannaccone E, et al. Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol. 2012;19(9):1256\u201360. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03753.x.","journal-title":"Eur J Neurol"},{"key":"2312_CR23","doi-asserted-by":"publisher","first-page":"707837","DOI":"10.3389\/fneur.2021.707837","volume":"12","author":"F Fornander","year":"2021","unstructured":"Fornander F, Solheim T, Eisum AV, et al. Quantitative Muscle MRI and Clinical Findings in Women With Pathogenic Dystrophin Gene Variants. Front Neurol. 2021;12:707837. https:\/\/doi.org\/10.3389\/fneur.2021.707837.","journal-title":"Front Neurol"},{"issue":"5","key":"2312_CR24","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/mus.28235","volume":"70","author":"BM Jenkins","year":"2024","unstructured":"Jenkins BM, Dixon LD, Kokesh KD, et al. Skeletal muscle symptoms and quantitative MRI in females with dystrophinopathy. Muscle Nerve. 2024;70(5):988\u201399. https:\/\/doi.org\/10.1002\/mus.28235.","journal-title":"Muscle Nerve"},{"issue":"2","key":"2312_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, Van Deutekom JC, Fokkema IF, et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34(2):135\u201344. https:\/\/doi.org\/10.1002\/mus.20586.","journal-title":"Muscle Nerve"},{"issue":"2","key":"2312_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00415-025-12896-6","volume":"272","author":"MR de Brito","year":"2025","unstructured":"de Brito MR, Rezende TJR, da Silva Passos S, Iwabe C, Martinez ARM, Nucci A, Fran\u00e7a MC Jr. Cognitive changes and brain structural abnormalities in female carriers of DMD pathogenic variants. J Neurol. 2025;272(2):152. https:\/\/doi.org\/10.1007\/s00415-025-12896-6.","journal-title":"J Neurol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02312-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:57:08Z","timestamp":1793066228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02312-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2312"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02312-8","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants or their legal guardians provided written informed consent to participate.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of anonymized clinical data and images, including MRI and muscle pathology images, was obtained from the participants\u2019 legal guardians.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"155"}}